The human endometrium is incredibly dynamic, undergoing monthly cycles of growth and regression during a woman's reproductive life. Endometrial repair at the cessation of menstruation is critical for reestablishment of a functional endometrium receptive for embryo implantation; however, little is understood about the mechanisms behind this rapid and highly efficient process. This study utilized a functional mouse model of endometrial breakdown and repair to assess changes in endometrial vasculature that accompany these dynamic processes. Given that adult endometrial stem/progenitor cells identified in human and mouse endometrium are likely contributors to the remarkable regenerative capacity of endometrium, we also assessed label-retaining cells (LRC) as candidate stromal stem/progenitor cells and examined their relationship with endometrial vasculature. Newborn mouse pups were pulse-labeled with bromodeoxyuridine (BrdU) and chased for 5 wk before decidualization, endometrial breakdown, and repair were induced by hormonal manipulation. Mean vessel density did not change significantly throughout breakdown and repair; however, significantly elevated endothelial cell proliferation was observed in decidual tissue. Stromal LRC were identified throughout breakdown and repair, with significantly fewer observed during endometrial repair than before decidualization. A significantly higher percentage of LRC were associated with vasculature during repair than before decidualization, and a proportion were undergoing proliferation, indicative of their functional capacity. This study is the first to examine the endometrial vasculature and candidate stromal stem/progenitor cells in a functional mouse model of endometrial breakdown and repair and provides functional evidence suggesting that perivascular LRC may contribute to endometrial stromal expansion during the extensive remodeling associated with this process.
INTRODUCTION
The human endometrium undergoes cyclical changes each month in preparation for implantation. This includes cell proliferation, differentiation, and eventual breakdown and shedding during menstruation. Menstruation is a process that occurs in humans and a limited number of other species. The process of menstruation is rapid and efficient, ensuring complete endometrial repair month after month during a woman's reproductive life (for review see [1] ). Although largely governed by female hormones estrogen and progesterone, the dynamic endometrium is also significantly influenced by the production of local regulators, including cytokines and growth factors [1, 2] .
It has long been hypothesized that endometrial stem/ progenitor cells may play a key role in mediating endometrial repair and subsequent tissue regeneration following menstruation [3] [4] [5] [6] . The first evidence for these concepts, however, only occurred recently with the initial identification of small populations of clonogenic endometrial epithelial and stromal cells, indicating the presence of at least two types of adult stem/ progenitor cells within the endometrium [7] . Since this finding in 2004, a number of studies have sought to identify markers that may assist in identification of these rare cells [8] ; however, functional evidence for their role in endometrial repair following menstruation is still limited.
Epithelial and stromal label-retaining cells (LRC) have recently been identified as candidate stem/progenitor cells in mouse endometrium [9] [10] [11] [12] . The LRC approach identifies stem/progenitor cells by their quiescent nature [13] [14] [15] . This technique relies on pulse labeling the majority of cell nuclei with a DNA synthesis marker such as bromodeoxyuridine (BrdU) at a time when stem cells are proliferating. Labeling is followed by a chase period where slower cycling stem cells will retain the BrdU label for longer periods of time, while more mature, rapidly cycling transit amplifying cells dilute the label to undetectable levels. BrdU immunohistochemistry localizes the LRC and identifies their surrounding niche [10, 15] .
Using the LRC technique, we have previously identified candidate epithelial stem/progenitor cells in a functional model of endometrial breakdown and repair [11] . We showed that glandular epithelial cells retain the BrdU label for longer periods than the luminal epithelial population, that they are distinct in their capacity to proliferate during endometrial repair, and that during repair they strongly express estrogen receptor-a (ESR1). In contrast, the luminal epithelium underwent rapid proliferation and dilution of LRC. We further characterized candidate epithelial stem/progenitor cells in a separate model of estrogen-induced endometrial regeneration [15] . Here our data indicated that candidate epithelial stem/ progenitor cells played an important role in glandular development, and we confirmed that mature epithelial cells were likely to undergo self-replication in cycling endometrium [15] .
In this study we have used a functional model of endometrial breakdown and repair to identify stromal LRC as putative stromal stem/progenitor cells to investigate their potential role in mediating the tissue remodeling and hormone-independent endometrial repair observed in this model [16] . Given that human endometrial stromal/mesenchymal stem cells are perivascular [17, 18] , we have also utilized the mouse model to examine endometrial vasculature throughout endometrial breakdown and repair, with particular focus on PECAM1 (also known as CD31)-positive endothelial cells. As mice have a bicornuate uterus, this model has the unique capacity to provide untreated uterine horns within the same mouse during treatment. As a consequence, the control horns are exposed to all the same hormonal conditions as the treated horns. Thus, a secondary aim was to assess changes in endometrial vasculature during endometrial breakdown and repair in relation to estrogen and progesterone in the untreated horns.
MATERIALS AND METHODS

Animals
Female C57BL/6 mice of 6-10 wk of age (Monash Animal Services) were housed in standard conditions with food and water provided ad libitum and a constant light cycle of 12L:12D (lights on from 0800 to 2000 h). Ethics approval for this project was granted by the Monash Medical Centre Animal Ethics Committee A.
Mouse Model of Endometrial Breakdown and Repair
At 3 days of age pups were pulse labeled with BrdU as previously described [10] . At 5 wk of age, the standard protocol to induce endometrial breakdown and repair was started, as previously described [19] . Briefly, under xylazine/ ketamine-induced anesthesia, mice were ovariectomized 7 days prior to the first of three daily s.c. injections of 100 ng 17b-estradiol (Sigma Chemical Co., St Louis, MO) in arachis oil at approximately 0900 h. After resting the mice for 4 days, progesterone implants were inserted s.c. into the back of each mouse. Simultaneously, the mice received a single s.c. injection of progesterone (50 ng) in arachis oil, and an injection of 5 ng 17b-estradiol in arachis oil was given at approximately 0900 h on that and the subsequent 2 days. At approximately 1100 h on the day of the final 17b-estradiol injection, 20 ll of sesame oil was injected into the lumen of the right uterine horn of each mouse to induce decidualization. The left horn remained untreated as a control. The progesterone implants were removed 49 h after oil injection. Groups of mice (n ¼ 6) were killed 1 day after the final priming estrogen injections (Fig. 1, time  A) , at the time of endometrial decidualization (Fig. 1, time B) , following endometrial breakdown (Fig. 1, time C) , or at the time of endometrial repair ( Fig. 1, time D) . Uteri were cleaned of fat and weighed. For studies examining endometrial vasculature, the control horn (no decidual stimulant applied) was also collected. Tissue was cut into pieces and fixed in 4% paraformaldehyde (PFA) for 4 h at room temperature (RT) and processed to wax in an orientation that would provide longitudinal sections [11] .
PECAM1 and Alpha Smooth Muscle Actin (ACTA2) Immunohistochemistry-Analysis of Endometrial Vasculature PECAM1 and ACTA2 immunohistochemistry was conducted on longitudinal sections of uteri from animals at four different stages during the mouse model of endometrial breakdown and repair to identify endometrial vasculature. Paraffin sections (3 lm) of PFA-fixed tissues were dewaxed in Xylene and rehydrated through descending grades of ethanol. Sections for PECAM1 were treated with 0.1% pepsin in 3% glacial acetic acid for 10 min at 378C for antigen retrieval. Sections were immersed in Dako blocking buffer (Dako, Glostrup, Denmark) for 10 min and incubated for 1 h at 378C with primary antibody, rat monoclonal PECAM1 (IgG 1 ; PharMingen, San Diego, CA) at 0.5 lg/ml, or mouse monoclonal ACTA2 (IgG 2a ; Dako) at 70 lg/ml, diluted in 1% bovine serum albumin in PBS (BSA/PBS). A negative control was included for each tissue section by substitution of primary antibody with a matching concentration of rat IgG 1 or mouse IgG 2a . For PECAM1, biotinylated anti-rat IgG (Chemicon, Temecula, CA) diluted 1:200 in 1% BSA/Tris-buffered saline (TBS) was applied for 1 h at RT, and the slides were washed as described above. One drop of Dako LSAB þ AP streptavidin (Dako) was then applied for 15 min at RT before sections were washed, and Vector Blue (Vector, Burlingame, CA) was applied for 10 min at RT. Sections were washed with distilled H 2 O, and slides were mounted with Ultramount (Dako). For ACTA2, the mouse Envision (horseradish peroxidase) system (Dako) was applied for 30 min at RT, and slides were washed as above. Diaminobenzidine (DAB) solution (Dako) revealed the ACTA2 staining. Sections were then lightly counterstained with Harris hematoxylin (Accustain; Sigma Diagnostics, Castle Hill, NSW, Australia), dehydrated, and mounted using DPX mounting medium (BDH Laboratory Supplies, Poole, U.K.).
PECAM1/Proliferating Cell Nuclear Antigen Immunohistochemistry-Analysis of Proliferating Endothelial Cells
Double PECAM1/proliferating cell nuclear antigen (PCNA) immunohistochemistry was conducted on longitudinal sections of uteri from animals at the four stages of endometrial breakdown and repair. PECAM1 staining was revealed using Vector Blue as described above. Sections were then microwaved for 20 min followed by cooling to RT for 30 mins. They were washed for 10 min in PBS, and Dako protein block was applied for 10 min at RT. Excess block was drained from sections before mouse monoclonal PCNA (Novocastra, Newscastle, U.K.) was applied at 0.9 lg/ml in 1% BSA/PBS for 1 h at 378C. For negative controls, primary antibody was substituted with mouse IgG 2a diluted to the same concentration. Sections were then washed as described previously before mouse Envision system was applied for 30 min at RT. Sections were then washed as described above and mounted with Ultramount.
Counting of Endothelial Cells
Endothelial staining as determined by PECAM1 immunohistochemistry was quantified to distinguish differences in microvessel density during endometrial breakdown (Fig. 1 , time C) and repair ( Fig. 1, time D) . Longitudinal tissue sections were only included in the analysis of their respective groups if their morphology matched our previously published morphological scoring system [20] . Vessel density was determined by assessment of the number of vessel profiles per unit area by counting 8-15 different areas for each longitudinal section for each animal. To determine the percentage of proliferating vessels, vessel profiles containing one or more proliferating endothelial cells were counted and expressed as a percentage of total vessel profiles [21] . Finally, the ratio of the number of proliferating endothelial cells per vessel was determined by counting the total number of proliferating endothelial cells and dividing it by the total number of vessel profiles counted [22] . Counts were conducted on areas of decidua, endometrial breakdown, and within the subepithelial stroma. Control horns (that did not undergo decidualization, breakdown, or repair) were collected at the same times as the treated horns were collected. Control horns were collected to assess differences resulting from the hormonal profile rather than events of decidualization and breakdown. For each group, n ¼ 3-6 animals were assessed. Data was expressed as mean 6 SEM.
BrdU Immunohistochemistry-Analysis of LRC
BrdU immunohistochemistry was conducted on longitudinal sections of uteri from animals at four stages during the mouse model of endometrial breakdown and repair, as previously described [11, 15] , to identify endothelial or stromal LRC. The primary antibody used was sheep anti-BrdU (Biodesign, Saco, ME) diluted in 1% fetal calf serum (FCS)/PBS to 8 lg/ml. A negative control was included for each tissue section by substitution of primary antibody with a matching concentration of sheep IgG. Biotinylated donkey anti-sheep IgG (Jackson ImmunoResearch, West Grove, PA) diluted at 1:200 (final concentration of 4 lg/ml) in 1% FCS/TBS was applied for 30 min at RT, and the slides were washed as described above. The StrepABC horseradish peroxidase kit (Dako) was then applied according to the manufacturer's instructions for 30 min at RT, and slides were washed as described above. DAB KAITU'U-LINO ET AL. solution revealed the BrdU staining. Sections were lightly counterstained with Harris hematoxylin, dehydrated, and mounted using DPX mounting medium.
BrdU Counting System-Quantification of LRC
Longitudinal tissue sections were only included in the analysis of their respective groups if their morphology matched our previously published scoring system [20] (n ¼ 3-6 animals per group). BrdU staining dilutes from the nucleus during cell division and is observed as partially stained nuclei [11] . As we were interested only in identifying long-lasting LRC that had either not undergone proliferation or had only undergone one cell cycle, we only counted cells that had greater than 75% of their nucleus as BrdU positive. Data was expressed as mean 6 SEM.
BrdU/PCNA Immunofluorescence-Analysis of Proliferating Stromal or Endothelial LRC Double BrdU/PCNA immunofluorescence was conducted on longitudinal sections of uteri from animals in which uteri were collected following estrogen injections and during endometrial repair. Paraffin sections (3 lm) of PFA-fixed tissues were dewaxed in Xylene and rehydrated through descending grades of ethanol. Sections were microwaved for 20 min in citrate buffer (pH 6.0) before cooling to RT for 30 mins. The protocol for BrdU immunohistochemistry was followed as detailed earlier. Alexa Fluor 568-conjugated donkey anti-sheep IgG (Invitrogen, Grand Island, NY) was diluted 1:800 in 1% FCS/PBS and applied for 45 min at RT in a darkened chamber. Sections were washed in PBS for 10 min before 20% normal goat serum in PBS was applied for 20 min at RT. Primary antibody (PCNA) was then diluted in 10% normal goat serum (NGS)/ PBS/0.1% Tween 20 and applied for 1 h 15 min at RT before sections were washed with PBS. Mouse IgG was applied at a matching concentration for negative controls. Biotinylated goat anti-mouse IgG (Jackson ImmunoResearch) was diluted 1:200 in 10% NGS/PBS/0.1% Tween 20 and applied for 45 min at RT. Sections were washed with PBS and Alexa Fluor 488-streptavidin (Invitrogen) diluted 1:800 in 10% NGS/PBS/0.1% Tween 20 and applied for 45 min at RT. Sections were then washed in PBS and 4 0 ,6-diamidino-2-phenylindole (DAPI; Invitrogen) diluted in deionized water to a concentration of 25 lg/ml was applied for 5 min at RT. Sections were then rinsed with deionized water before wet mounting in Fluormount and stored in the dark. Imaging of sections was carried out using a Leica DMR upright fluorescence microscope with images acquired using a 403 objective and a color camera. BrdU þ ) cells were also counted, and the percentage of total stromal cells was similarly calculated as previously described [15] . Data was expressed as mean 6 SEM.
Statistical Analysis
After testing for normal distribution using a Kolmogorov-Smirnov test, D'Agostino and Pearson omnibus normality test, and Shapiro-Wilk normality test, statistical analysis was performed using the Kruskal-Wallis test, followed by a Dunn multiple comparisons post hoc test. For comparisons between two groups, the Mann-Whitney test was used. All statistical analysis was carried out using PRISM version 4.03 for Windows (GraphPad, San Diego, CA). P 0.05 was taken as significant.
RESULTS
Microvessel Density During Decidualization, Breakdown, and Repair PECAM1 immunostaining was used to assess microvessel density during decidualization, breakdown, and repair. Strong PECAM1 staining was observed throughout the decidual zone, with large, elaborate vascular networks apparent ( Fig. 2A) . Following progesterone withdrawal, many of these vascular networks were destroyed, and fewer PECAM1-positive vessels were observed (Fig. 2E) within the breakdown region, although this difference was not significant (Fig. 2M) , possibly due to the presence of vessels at the endometrial/myometrial junction as observed previously [10] . During endometrial repair, PECAM1-positive vessels were observed in the ''basalis'' stromal zone underlying the repaired luminal epithelium (Fig.  2I ), but the microvessel density did not differ significantly from breakdown and decidualization zones (Fig. 2M) . In the untouched control horns, no differences in PECAM1-positive vessel profiles were apparent (Fig. 2, B, F, and J) , despite the hormonal profile of the mice altering from high progesterone during decidualization to absent hormones during breakdown and subsequent repair. This observation was reflected in the microvessel densities, where no significant differences between control groups were observed (Fig. 2M ).
ACTA2 Coverage of Vessels During Endometrial Breakdown and Repair
Pericytes and smooth muscle cells stabilize blood vessels and can be detected by ACTA2 immunoreactivity [22] . During   FIG. 1 . Timeline of mouse model of endometrial breakdown and repair. Mice were pulse labeled with BrdU at 3 days of age (3do), twice daily for 3 days, and the label was then chased for 5 wk (5w), after which mice were ovariectomized (OVX). One week later (6w þ 0), estrogen (E2) injections were administered for 3 consecutive days. Mice were then rested for 4 days before a progesterone (P) injection was administered and a progesterone implant inserted. On the same day and for the following 2 days, 5 ng 17b-estradiol was injected s.c. to prime the uterus for decidualization. On Day 8, a decidual stimulus was applied, and 49 h later (0h) the progesterone implant was withdrawn. Tissue was collected 24 h following the final estrogen injection (A), when tissue had decidualized (B), at the time of endometrial breakdown (C), and during endometrial repair (D). At these times both the treated and control horn were collected for ongoing analysis.
PERIVASCULAR LRC AND ENDOMETRIAL REPAIR decidualization, ACTA2 staining was not observed within the decidual zone (Fig. 2C ) but was only detected within the ''basalis-like'' stromal area that had not undergone decidualization (adjacent to the myometrium) and between decidual regions [11] . During breakdown and repair, ACTA2 staining was observed within the stroma adjacent to the myometrium (Fig. 2K) . ACTA2 immunostaining was evenly distributed and consistently observed on blood vessels throughout the endometrial stroma in control tissue at all times (Fig. 2, D , H, and L).
Identification of Proliferating Endothelial Cells
A large number of PECAM1-positive vessel profiles were present in decidual tissue (Fig. 2M ). The mouse model is one of extensive tissue remodeling during decidualization, endometrial breakdown, and repair. In order to ascertain whether KAITU'U-LINO ET AL.
angiogenesis was occurring during this remodeling, we examined endothelial cell proliferation (Fig. 3) . In decidual tissue a significantly higher (P , 0.01) percentage of vessel profiles contained one or more proliferating endothelial cells compared to the control horn (Fig. 3, A, D, and G) . Likewise, the number of proliferating endothelial cells per vessel profile was also significantly higher in decidual tissue compared to control (Fig. 3H) . No significant differences were observed for proliferating endothelial cells or vessels between treated and controls at any other time points (Fig. 3, G and H) .
Identification of Stromal LRC During Endometrial Breakdown and Repair
To assess whether stromal stem/progenitor cells are present following endometrial breakdown, we set out to identify the PERIVASCULAR LRC AND ENDOMETRIAL REPAIR location of candidate stromal stem/progenitor cells during endometrial breakdown and repair using the LRC method.
Following a chase period of approximately 6 wk, BrdU immunohistochemistry was assessed in the stromal compartment (Fig. 4, A-C) prior to endometrial breakdown, during decidualization, and during endometrial repair. Following estrogen injections, 11.5% 6 6.1% (n ¼ 6) of total stromal cells were BrdU positive (Fig. 4, A and C) . The BrdU-positive stromal cells were scattered throughout the endometrial horn, with no obvious pattern of localization. At the time of Significantly fewer stromal LRC were identified during repair (C). Double BrdU (brown)/PECAM1 (blue) (D, E) and BrdU (brown)/ACTA2 (blue) (G, H) immunochemistry identified a small population of LRC that were perivascularly localized. Round arrowheads indicate LRC associated with vasculature; arrows indicate LRC not associated with vasculature. To quantify perivascularly located LRC, the percentage of LRCassociated with PECAM1-positive vasculature was determined at the time of 17b-estradiol injection and during endometrial repair and expressed as percentage of total stromal cells (F) or as percent of total LRC (I). To identify proliferating LRC, double immunofluoresence for BrdU (red; J, M) and PCNA (green; K, N) was carried out at the time of estrogen injection (J-L) and during endometrial repair (M-O). Double-positive cells were identified as yellow in the merged images (L, O) and are indicated by a white arrow. The percentage of proliferating stromal cells was determined at the time of estrogen injection, during decidualization, and during endometrial repair (P) and the percentage of proliferating LRC was determined at the time of estrogen injection and during repair (Q). Data are expressed as mean 6 SEM, n ¼ 4-6 mice per group except in Q, where the repair group is n ¼ 3 mice. *P 0.05 between decidua and estrogen-injected samples. Bars = 100 lm.
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decidualization, only cells with a decidual morphology were examined, with only 0.14% 6 0.11% (n ¼ 4) of decidual cells identified as BrdU positive (data not shown). During endometrial repair, 0.73% 6 0.28% (n ¼ 3) of stromal cells were identified as BrdU positive (Fig. 4, B and C) , which was significantly (P , 0.05) fewer than those observed following estrogen injections.
Some Stromal LRC Are Associated with PECAM1-Positive Endometrial Vasculature
Given previous reports showing that approximately one third of endometrial LRC can be found in a perivascular location [10] , we carried out double immunohistochemistry for BrdU/PECAM1 (Fig. 4, D and E) and BrdU/ACTA2 (Fig. 4, G  and H) . In the estrogen-injected group, we observed that LRC associated with PECAM1-positive vessels comprised 0.9% 6 0.3% (n ¼ 6) of total stromal cells, which was not significantly different to those observed during repair (0.4% 6 0.13%, n ¼ 3; Fig. 4F ). When we assessed LRC associated with PECAM1 vasculature as a percentage of total LRC, we observed a significantly higher percentage in the repair group compared to the estrogen-injected group (9.4% 6 3.87% vs. 2% 6 0.44%, n ¼ 3, P ¼ 0.05; Fig. 4I ). We also observed some LRC associated with ACTA2-positive vasculature during endometrial breakdown and repair (Fig. 4, G and H) , particularly near the endometrial/myometrial junction as reported previously [10, 11, 23] .
Identification of Proliferating LRC
Given that approximately 12% of stromal LRC proliferate in response to estrogen-induced endometrial regeneration [15] , we investigated whether stromal LRC in this breakdown-andrepair model initiated proliferation. To assess this functional capacity of the identified stromal LRC, we carried out dual immunofluorescence for PCNA/BrdU to identify LRC undergoing proliferation (Fig. 4, J-O) . Initially, we quantified the percentage of proliferating stromal cells (PCNA positive) following estrogen injection, in decidual tissue, and during endometrial repair (Fig. 4P) . We observed the highest percentage of proliferating stromal cells during decidualization, when 25.6% 6 3.82% (n ¼ 5) of decidual cells were PCNA positive, significantly higher (P , 0.05) than that observed in the estrogen-injected group (9.35% 6 1.45%, n ¼ 5; Fig. 4P) . No difference for percentage of PCNA-positive cells was identified between the estrogen-injected group and repair group (Fig. 4P) . Very low percentages of double-positive proliferating stromal LRC (BrdU þ PCNA þ ) were identified in the estrogen-injected group (0.3% 6 0.1%, n ¼ 5) when assessed as a percentage of total stromal cells (Fig. 4 , J, K, L, and Q); however, this equated to 22.8% 6 7.4% (n ¼ 5) of total BrdU þ stromal cells. In the repair group, BrdU/PCNA-positive cells were only identified in one of three animals assessed, with a mean of 0.05% 6 0.04% (n ¼ 3); Fig. 4 , M, N, O, and Q).
DISCUSSION
In this study, we have demonstrated the dynamic remodeling of endometrial vasculature associated with endometrial breakdown and repair. We have shown that endothelial cells undergo extensive proliferation to support the rapidly expanding decidua and that many of these vessels are destroyed during endometrial breakdown. We have also demonstrated that vascular proliferation during repair is limited. To assess the contribution of stromal stem/progenitor cells, we utilized an LRC approach and demonstrated that a small population of candidate stromal stem/progenitor cells undergo proliferation during the repair period and are closely associated with endometrial vasculature.
Our examination of endometrial vasculature provided evidence of significant angiogenesis during decidualization, but not during endometrial repair. In this mouse model of decidualization, breakdown, and repair (MMBR), we examined very early epithelial repair, and thus it is possible that the vessels we observed may have remained following breakdown. If this was the case, vascular cells may only proliferate during later estrogen-driven growth and development, which could be equated with that observed during the human proliferative phase. Thus, in this model, as in humans, we demonstrate a rapid vascularization of the decidual tissue. Following endometrial breakdown we showed that the surface epithelium repairs before the proliferative expansion of the endometrium occurs. Although beyond the scope of this study, it is expected that extension of the model into a proliferative phase with estrogen administration would stimulate angiogenesis within the expanding stromal compartment.
To identify whether candidate stromal stem/progenitor cells are involved in endometrial remodeling, we examined stromal LRC at different stages of our MMBR model. We have shown that following a long-term chase, a small proportion of stromal LRC are identifiable within the endometrium, consistent with previously published studies [10, 15] . Stromal growth occurs during the 6-wk chase period (Postnatal Days 3-56), and hence BrdU dilution is due to postnatal growth and development of the prepubertal uterus rather than cyclical growth and regression. Since endometrial stromal cells are well known for their estrogen responsiveness (for review see [24, 25] ), we first examined the stromal compartment immediately following a series of estrogen injections required to prime the endometrium for decidualization. Our previous data [10, 11] showed a high labeling efficiency for endometrial stromal cells (65%) in mice pulse labeled with BrdU at 3 days of age [10] . After a 6-wk chase period and following the estrogen injections used in our model, we observed that 11.5% of stromal cells retained the BrdU label (LRC), indicating significant dilution consistent with previous reports [10, 15] . At this time, approximately 10% of stromal cells and 22% of total LRC proliferated (PCNA positive), consistent with a different estrogen-induced endometrial regeneration model [15] , indicating that LRC preferentially proliferate in response to estrogen stimulation. This important finding provides snapshot evidence that LRC are functional and capable of proliferation and are not cells that have simply incorporated BrDU in their penultimate cell division. We suggest that this population of functional LRC with proliferative capacity represent a pool of candidate stem/progenitor stromal cells.
The highest stromal proliferation rates were observed during decidualization, when 25% of decidual cells were identified as strongly positive for PCNA. In line with this high level of proliferation, very few true decidual cells were identified as stromal LRC, reflecting rapid dilution of the label to undetectable levels within this highly proliferative population. Thus it is likely that stromal LRC themselves are not recruited to decidualize, but remain in the basalis region in readiness for endometrial regeneration following menstrual repair, a notion supported by our previous observations that stromal LRC are located at the endometrial/myometrial junction [10] .
In human endometrium, the basalis is suggested as the likely niche for stromal stem/progenitor cells [6, 26] . Previous work from our laboratory has identified CD146 (official symbol MCAM) and W5C5 as endometrial stromal stem cell markers [17, 18, 27] . Furthermore, human endometrial PERIVASCULAR LRC AND ENDOMETRIAL REPAIR
CD146
þ PDGFR-b þ and W5C5 þ cells are clonogenic and multipotent [17, 18] . Using these markers, a perivascular location was identified in both the functionalis and basalis, suggesting a perivascular niche for the endometrial mesenchymal/stromal stem/progenitor cell population. More specifically, these perivascular cells are directly adjacent to endothelial cells, and their expression of additional markers indicates they are pericytes [17, 28] . This, together with our previous observations in murine endometrium [10] , led us to examine LRC in relation to PECAM1-and ACTA2-positive endometrial vasculature. Our observation of significantly more perivascular LRC (as a percentage of total LRC) during endometrial repair than in the estrogen-injected group suggests that LRC may be recruited to the perivascular location possibly from the bone marrow [29] during or following the insult of endometrial breakdown. Alternatively, many of the BrdUpositive stromal cells remaining after the 5-wk chase and estrogen injections may not be true stromal LRC, due to the slow rate of stromal turnover during endometrial development (compared to epithelial LRC) [10, 15] , and hence stromal BrdU dilution is incomplete at this time point in the model. This would account for the smaller number of stromal LRC associated with the perivascular niche at this time. We believe that this population of nonvascular-associated BrdU-positive cells are unlikely to be stromal stem/progenitor cells, but are more likely to have either been labeled on their penultimate cell division and/or are leukocytes derived from the bone marrow. It is likely that the newly identified lineage marker W5C5 [18] will be a tool that will more clearly elucidate the location of stromal stem/progenitor cells and distinguish them from those LRC not associated with endometrial vasculature and not considered to be stromal stem/progenitor cells.
In summary, this study has demonstrated the vascular changes that accompany endometrial breakdown and repair and provided evidence for the existence of a population of stem/ progenitor cells involved in proliferation and expansion of the endometrial stroma during the extensive remodeling observed throughout this process.
